September 20, 2025PharmaciaOpen Access

Clinical pharmacist interventions in infectious disease service: types, acceptance, and cost savings analysis using a customized electronic intervention system

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective analysis reveals acceptance of clinical pharmacist interventions in infectious disease, indicating significant cost savings.

Clinical pharmacist interventions resulted in an estimated cost savings of approximately 234,666 Saudi Riyals.
The most common interventions documented were pharmacokinetics dosing and renal dosing by clinical pharmacists.
A total of 464 interventions were analyzed across 187 patients in the infectious disease consultation service.
Cost savings from clinical pharmacist involvement highlight the importance of customized electronic reporting systems.

Bashayer M. AlShehail (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis reveals acceptance of clinical pharmacist interventions in infectious disease, indicating significant cost savings.